Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries

Br J Pharmacol. 2000 Aug;130(7):1699-705. doi: 10.1038/sj.bjp.0703484.

Abstract

The periarterial electrical nerve stimulation (30 s trains of pulses at a frequency of 1, 4 or 10 Hz) induced a double peaked vasoconstriction consisting of an initial transient constriction (first peak) followed by a prolonged response (second peak) in the isolated, perfused canine splenic artery. At low frequencies (1 and 4 Hz), a neuropeptide Y (NPY) Y(1) receptor antagonist BIBP 3226 (0.1-1 microM) produced a dose-dependent inhibitory effect on the second peak, but did not modify the first peak. At a high frequency (10 Hz), 1 microM BIBP 3226 induced a slight, but significant inhibition on both the first and second peaked responses. At a low frequency (1 Hz), the first peak was not influenced by blockade of alpha(1)-adrenoceptors or NPY Y(1) receptors with prazosin (0.1 microM) or BIBP 3226 (1 microM), respectively, but abolished by P2X receptor desensitization with alpha,beta-methylene ATP (alphabeta-m ATP, 1 microM). At a high frequency (10 Hz), the first peak was mostly inhibited by alphabeta-m ATP and partially by prazosin and BIBP 3226. On the other hand, the second peak at a low frequency was largely decreased by BIBP 3226 and partially by prazosin and alphabeta-m ATP, whereas at a high frequency, it was largely attenuated by prazosin and partially by alphabeta-m ATP and BIBP 3226. The results suggest that at a low frequency, the firstly transient constriction of double peaked responses is mainly induced via an activation of P2X-receptors, whereas at a high frequency, it is mostly mediated by the P2X-receptors, and partially by alpha(1)-receptors and NPY Y(1)-receptors. The secondary prolonged vasoconstriction at frequencies used is predominantly mediated via both alpha(1)-receptor and NPY Y(1) receptor activations, and in part by P2X-receptors. Furthermore, an activation of NPY Y(1) receptors may play an important role in evoking the prolonged vasoconstrictor response to longer pulse trains of stimulation at a low frequency, whereas an alpha(1)-adrenoceptor activation exerts a main vasomotor effect for the prolonged response at a high frequency.

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives*
  • Adenosine Triphosphate / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Arginine / analogs & derivatives*
  • Arginine / pharmacology*
  • Dogs
  • Drug Interactions
  • Electric Stimulation
  • Female
  • In Vitro Techniques
  • Male
  • Nerve Tissue / drug effects
  • Nerve Tissue / physiology
  • Neuropeptide Y / analogs & derivatives*
  • Neuropeptide Y / pharmacology
  • Norepinephrine / pharmacology
  • Prazosin / pharmacology
  • Receptors, Neuropeptide Y / antagonists & inhibitors*
  • Splenic Artery / drug effects*
  • Splenic Artery / physiology
  • Vasoconstriction / drug effects*

Substances

  • Adrenergic alpha-Antagonists
  • Anti-Anxiety Agents
  • BIBP 3226
  • Neuropeptide Y
  • Receptors, Neuropeptide Y
  • neuropeptide Y-Y1 receptor
  • neuropeptide Y, Leu(31)-Pro(34)-
  • Adenosine Triphosphate
  • Arginine
  • alpha,beta-methyleneadenosine 5'-triphosphate
  • Norepinephrine
  • Prazosin